Conversations

Investing in Europe’s B2B Production Stack for a Better Food System

Kost Capital’s Bodil Sidén on the fund-and-studio model, founder signals that matter at pre-seed, and AI.

Oct 6 •

Eshan Samaranayake

A Scientist-Founder’s Journey to Make Biotech Research Reliable and Ethical

My conversation with Katie Bashant Day, the founder of Media City Scientific

Oct 17, 2024 •

Eshan Samaranayake

Laying the Foundation for Smart Protein Leadership in India

My conversation with Devika Suresh, Innovation Specialist at The Good Food Institute India

Sep 12, 2024 •

Eshan Samaranayake

Bridging Science and Business to Support Startups Using Biomanufacturing

My conversation with biotech consultant and ex-CSO of Vow, James Ryall

Jun 21, 2024 •

Eshan Samaranayake

Financing and Developing Infrastructure for the Bioeconomy

Q&A with Synonym's co-founder, Joshua Lachter

Mar 20, 2024 •

Eshan Samaranayake

Connecting Innovators, Investors, and Incumbents to Drive the Bioeconomy

My conversation with Bioshyft's founder, Gerrit Feuerriegel

Mar 12, 2024 •

Eshan Samaranayake

Turning Agrifood Byproducts Into Nutrient-Rich B2B Ingredients

My conversation with Rebecca Palmer, Chief Marketing Officer of Terra Bioindustries

Feb 22, 2024 •

Eshan Samaranayake

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts